IELSG46 Study

IELSG46 Integrated molecular and clinical profiling to optimize outcome prediction in Splenic Marginal Zone Lymphoma
Participants required: Biological samples of at least 300 subjects
Investigator responsible(s): D. Rossi
Objective(s): To develop and validate an integrated clinic-molecular model for an accurate survival prognostication of newly diagnosed SMZL.

Home | Go to Studies